News

Top FDA official resigns after agency shake-up under Trump: ‘It was time’
Michael Rogers, a top official at the Food and Drug Administration, announced Monday he is retiring amid the Trump ...
The Associated Press on MSN13d
FDA to rehire fired staffers who booked inspection trips, but other workers remain in limbo
The Food and Drug Administration is again trying to rehire some staffers who were recently fired amid mass layoffs at the ...
Top FDA inspection official to retire amid staff frustration
The official in charge of federal food and drug safety inspections will retire May 14. Michael Rogers, associate commissioner ...
Opinion
American Council on Science and Health13dOpinion
FDA in Crisis: How Trump Administration Downsizing Is Slowing Medical Innovation and Endangering Public Health
Recent reorganizations and "reductions in force" at the FDA have damaged the very backbone of our public health system. Gutted by Administration-initiated layoffs and seemingly ideologically-motivated ...
Devdiscourse11h
Global Health Updates: Major Investments and Policy Shifts Shape the Landscape
The latest health news highlights Sanofi's $20 billion U.S. investment through 2030, Merck's cancer drug expansion and the ...
JD Supra5d
From Offshore to Onshore: Considerations for Pharmaceutical Industry Stakeholders Amid New Domestic Drug Manufacturing EO
The White House on May 5, 2025 issued an executive order requiring the US Food and Drug Administration to find ways to facilitate the opening of ...
Arash Farin, Ming-Tai Huh and Sherry Jackman Share Insights on the Food & Beverage Industry in 2025
What's next for food & restaurants? Experts Arash Farin, Ming-Tai Huh & Sherry Jackman share crucial 2025 predictions on tech ...
Business Wire10d
ImmunityBio Requests an Urgent Meeting With FDA to Address the Change in the Agency’s Unambiguous Guidance on Jan 2025 to Submit a sBLA for NMIBC BCG Unresponsive Papillary ...
--(BUSINESS WIRE)--ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced that the Company received a Refusal to File (RTF) letter from the U.S. Food and Drug ...
The Manila Times1d
MeiraGTx Reports First Quarter 2025 Financial and Operational Results
LONDON and NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical-stage genetic medicines company, today announced financial and operational ...
kcra.com13d
FDA to rehire fired staffers who booked inspection trips, but other workers remain in limbo
FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION, OVER 3000 FROM THE FOOD AND DRUG ADMINISTRATION ... said the administration will “streamline operations and fix the broken systems left ...